Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mark, Moasser"'
Autor:
Neelima Vidula, Sally Greenberg, Laura Petrillo, Jimmy Hwang, Michelle Melisko, Andrei Goga, Mark Moasser, Mark Magbanua, John W. Park, Hope S. Rugo
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract We evaluated disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in patients with stage I-III breast cancer with >4 MM/mL DTC at baseline who received adjuvant zoledronic acid (ZOL). ZOL was administered every 4 weeks for 24 m
Externí odkaz:
https://doaj.org/article/3a9e793b4485485687e39189dbcf79b3
Autor:
Manuela Terranova-Barberio, Nela Pawlowska, Mallika Dhawan, Mark Moasser, Amy J. Chien, Michelle E. Melisko, Hope Rugo, Roshun Rahimi, Travis Deal, Adil Daud, Michael D. Rosenblum, Scott Thomas, Pamela N. Munster
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
ER-positive breast cancer patients do not usually respond to immunotherapy. In this phase II clinical trial, the authors report the safety and efficacy of combining vorinostat and pembrolizumab with tamoxifen in ER-positive breast cancers and provide
Externí odkaz:
https://doaj.org/article/64f0fec706954f5c93dba4c047a3944a
Autor:
Mark Moasser
Publikováno v:
Cancer Res
The pharmaceutical inactivation of driver oncogenes has revolutionized the treatment of cancer, replacing cytotoxic chemotherapeutic approaches with kinase inhibitor therapies for many types of cancers. This approach has not yet been realized for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0881b47c603a701ac1c4671bc930461f
https://doi.org/10.1158/0008-5472.can-22-1121
https://doi.org/10.1158/0008-5472.can-22-1121
Autor:
Pamela N. Munster, Scott Thomas, Tayeba Maktabi, Robin K. Kelley, Mark Moasser, Amy J. Chien, Andrew Gewitz, Jennifer A. Grabowsky, Manuela Terranova-Barberio, Nela Pawlowska, Jenna Z. Zhang, Jim Leng, Rahul Raj Aggarwal, Imke H. Bartelink, Mallika S. Dhawan
Purpose: The PARP inhibitor (PARPi) talazoparib may potentiate activity of chemotherapy and toxicity in cells vulnerable to DNA damage.Experimental Design: This phase I study evaluated the safety, tolerability, pharmacokinetics, and efficacy of talaz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fef46cd79198719c484e725942900fd
https://doi.org/10.1158/1078-0432.c.6527073
https://doi.org/10.1158/1078-0432.c.6527073
Autor:
Pamela N. Munster, Scott Thomas, Tayeba Maktabi, Robin K. Kelley, Mark Moasser, Amy J. Chien, Andrew Gewitz, Jennifer A. Grabowsky, Manuela Terranova-Barberio, Nela Pawlowska, Jenna Z. Zhang, Jim Leng, Rahul Raj Aggarwal, Imke H. Bartelink, Mallika S. Dhawan
Supplementary table 1 Observed and predicted blood toxicity profile at the start of Cycle 2 and Cycle 4 (A) and PK-toxicity model-predicted (B) neutrophil and platelet toxicity at cycle 2, day 1 and cycle 5 talozaparib 1mg/carboplatin AUC 1/5 weekly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439740471efabc624e71188857a3a7e0
https://doi.org/10.1158/1078-0432.22468851.v1
https://doi.org/10.1158/1078-0432.22468851.v1
Autor:
Kanwal Raghav, Mark Moasser
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
The oncogene ERBB2 encoding the receptor tyrosine-protein kinase erbB-2 (HER2) is frequently overexpressed or amplified and occasionally mutated in a variety of human cancers. The early discovery of this oncogene, its established oncogenic relevance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48b23da69a982e8d2cb6ab89e2e5f8a7
https://pubmed.ncbi.nlm.nih.gov/36574481
https://pubmed.ncbi.nlm.nih.gov/36574481
Autor:
Chi-Heng Wu, Linlin Wang, Chen-Yen Yang, Kwun Wah Wen, Brian Hinds, Ryan Gill, Frank McCormick, Mark Moasser, Laura Pincus, Weiyun Z. Ai
Publikováno v:
Blood advances, vol 6, iss 7
CD70 is a member of the tumor necrosis factor receptor superfamily. Emerging data indicate that CD70 may be a suitable target for various malignancies. We investigated the expression of CD70 in cutaneous and systemic T-cell lymphomas and conducted pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61f4aa6c79b7cda50b4964b72e2ea8a
https://escholarship.org/uc/item/37v4n6hb
https://escholarship.org/uc/item/37v4n6hb
Autor:
Gregory A. Masters, Lada Krilov, Howard H. Bailey, Marcia S. Brose, Harold Burstein, Lisa R. Diller, Don S. Dizon, Howard A. Fine, Gregory P. Kalemkerian, Mark Moasser, Michael N. Neuss, Steven J. O'Day, Olatoyosi Odenike, Charles J. Ryan, Richard L. Schilsky, Gary K. Schwartz, Alan P. Venook, Sandra L. Wong, Jyoti D. Patel
Publikováno v:
Journal of Clinical Oncology. 33:786-809
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8146e1fac36e1a379984ba0ed14d8f66
https://doi.org/10.1200/jco.2014.59.9746
https://doi.org/10.1200/jco.2014.59.9746
Autor:
Arti, Hurria, Anju, Hurria, Enid, Zuckerman, Katherine S, Panageas, Monica, Fornier, Gabriella, D'Andrea, Chau, Dang, Mark, Moasser, Mark, Robson, Andrew, Seidman, Violante, Currie, Catherine, VanPoznak, Maria, Theodoulou, Mark S, Lachs, Clifford, Hudis
Publikováno v:
Journal of the American Geriatrics Society. 54(7)
To examine the toxicity experienced by a cohort of older women receiving adjuvant chemotherapy for breast cancer and the longitudinal effect on their functional status and quality of life (QOL).A geriatric assessment measuring functional status, como
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9daf3cb93b256cfac0dc947cce9d9f4a
https://pubmed.ncbi.nlm.nih.gov/16866685
https://pubmed.ncbi.nlm.nih.gov/16866685
Autor:
Arti, Hurria, Carol, Rosen, Clifford, Hudis, Enid, Zuckerman, Katherine S, Panageas, Mark S, Lachs, Matthew, Witmer, Wilfred G, van Gorp, Monica, Fornier, Gabriella, D'Andrea, Mark, Moasser, Chau, Dang, Catherine, Van Poznak, Anju, Hurria, Jimmie, Holland
Publikováno v:
Journal of the American Geriatrics Society. 54(6)
To report on the longitudinal cognitive functioning of older women receiving adjuvant chemotherapy for breast cancer.Neuropsychological and functional status testing were performed before chemotherapy and 6 months after chemotherapy.Cancer center.Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a92d4a84dc57634aaef8b06a8870d71b
https://pubmed.ncbi.nlm.nih.gov/16776787
https://pubmed.ncbi.nlm.nih.gov/16776787